Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus FGBI Q1 2026 Earnings Strong EPS Beat Overshadowed by Modest Stock Decline ING Q1 2026 Earnings EPS Beats Estimates Stock Rises 22 FSUN Q1 2026 Earnings EPS Falls Short of Analyst Expectations Shares Edge Lower Chemours Q1 2026 Earnings Strong EPS Surprise Despite Ongoing Headwinds